新闻发布

AREX Biosciences Ltd. Partners with Leading Life Sciences Companies - arigo & RevMAb to Enhance Accessibility of Advanced Products in the Chinese Market

Hangzhou, China – July 2024– AREX Biosciences Ltd. is pleased to announce its collaboration with two prominent life sciences companies, arigo Biolaboratories Corp. and RevMAb Biosciences USA Inc., to increase the accessibility of high-quality antibody products and life sciences solutions in China. These strategic partnerships will bring cutting-edge research tools to the local market, further solidifying AREX Biosciences Ltd.’s role as a vital contributor to the advancement of scientific research and diagnostics in the region.


Expanding Product Accessibility through Partnership with arigo Biolaboratories Corp.



Effective from July 19, 2024, AREX Biosciences Ltd. has entered into a strategic partnership with arigo Biolaboratories Corp., a globally recognized leader in high-quality antibodies and related life sciences products. This partnership, which will continue through December 31, 2025, aims to enhance the availability of arigo’s comprehensive product line in China, supporting researchers and institutions with reliable and innovative solutions for their scientific endeavors.
arigo Biolaboratories Corp. is known for its extensive product portfolio, covering a broad range of applications in research and diagnostics. With this collaboration, AREX Biosciences Ltd. will play an essential role in facilitating access to these cutting-edge tools, ensuring that Chinese scientists have the resources they need to achieve breakthroughs in their work.


Introducing Innovative Antibody Technologies from RevMAb Biosciences USA Inc. 


Additionally, AREX Biosciences Ltd. has partnered with RevMAb Biosciences USA Inc. to introduce its revolutionary recombinant monoclonal antibody products to the Chinese market. RevMAb's unique technology, which eliminates the need for traditional cell fusion and hybridoma generation, provides superior sensitivity and specificity in antibody production. These advanced solutions are particularly beneficial in immunohistochemistry (IHC) and other diagnostic applications, meeting the growing demand for high-quality antibodies in China.

This collaboration with RevMAb will enable AREX Biosciences Ltd. to support the local research community by providing access to innovative antibody solutions that can drive scientific advancements and improve disease diagnostics.

Empowering Scientific Research and Diagnostics in China


These partnerships with arigo Biolaboratories Corp. and RevMAb Biosciences USA Inc. mark a significant milestone for AREX Biosciences Ltd. in its mission to bring the best life sciences solutions to China. By leveraging international expertise and local market knowledge, AREX aims to foster future collaborations that will contribute to the continued growth of scientific research and diagnostics in the region.


更多信息,请联系我们:


AREX Biosciences Ltd.
Room 315, Building A, No. 525 Xixi Road,
West Lake District, Hangzhou, China, 310063
Tel: 400-886-0853
Email: info@arexbio.com

Post time: 2024-10-24 10:01:41
© AREX 2024. All Rights Reserved. | 浙ICP备2024113709号-3 Sitemap